DUBLIN–(BUSINESS WIRE)–The “Optic Neuritis – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information on the therapeutics under development for Optic Neuritis (Ophtha…
Author: Business Wire
Acucela Meets with NASA and TRISH for Phase 1 Update for SS-OCT Project
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the company was invited to meet with NASA and the Tran…
Aerie Pharmaceuticals Announces Appointment of Michelle Senchyna, Ph.D., as Vice President, Clinical Development and Medical Affairs
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Amir Shojaei, PharmD, PhD, to Join iVeena Board of Directors
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (iVeena), a clinical stage biopharmaceutical company with developmental products in cornea and cataract, announces the appointment of Dr. Amir Shojaei to the iVeena Board of Directors. Dr. …
Zenni Sets Its Sights on Super Bowl Advertising
NOVATO, Calif.–(BUSINESS WIRE)– #eyewear–Zenni to Premiere First National Super Sunday Commercial featuring San Francisco 49ers All-Pro Tight End George Kittle.
EyeTech™ Launches EyeOn™, the Ultra-Compact Eye-Tracking Tablet Platform, Powered by Health AI, with FPGA for an Enhanced, Personalized User Experience
MESA, Ariz.–(BUSINESS WIRE)– #AAC–EyeOn is an all-in-one, ultra-slim eye gaze tablet that enables paralyzed individuals to control the device hands-free using only eye movements.
Midwest Vision Partners Announces Partnership with Specialty Eye Institute
CHICAGO & JACKSON, Mich.–(BUSINESS WIRE)–Midwest Vision Partners (“MVP”) is pleased to announce its partnership with Specialty Eye Institute (“SEI”). This represents MVP’s fourth partnership and bolsters its presence in both Michigan and Ohio. MVP is…
The Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmic Device Market is projected to reach more than US$ 67…
KLAS 2019 Report Names Modernizing Medicine’s EMA a Top-Rated Ophthalmology EMR System for Overall Customer Experience
BOCA RATON, Fla.–(BUSINESS WIRE)–KLAS 2019 Report Names Modernizing Medicine’s EMA a Top-Rated Ophthalmology EMR System for Overall Customer Experience
SmartHealth PayCard Offers Healthcare Providers and Millions of Americans Transformative Financial Solutions for Medical Expenses
DALLAS–(BUSINESS WIRE)–SmartHealth PayCard launches the first and only credit card restricted to healthcare, offering patients and providers innovative financial solutions.
Aldeyra Therapeutics Appoints Dr. Paul Karpecki to Anterior Segment Scientific Advisory Board
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics Appoints Dr. Paul Karpecki to Anterior Segment Scientific Advisory Board
Bruker Announces Date and Time of Fourth Quarter 2019 Earnings Release and Webcast
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation: Date and Time of Fourth Quarter 2019 Earnings Release and Webcast
Americans Want More from Eye Care But Fear Costs, Finds New Study
BALTIMORE, Md.–(BUSINESS WIRE)– #eye–Versant Health releases the 2020 Vision Wellness Study, finding that cost concerns could be keeping Americans from visiting their eye doctors.
Horizon Therapeutics plc Announces Changes in Research and Development Organization
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and exter…
Le programme clinique d’Ipsen pour le palovarotène dans la fibrodysplasie ossifiante progressive atteint le critère de futilité lors de l’analyse intérimaire prévue au protocole
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext : IPN ; ADR : IPSEY) a annoncé aujourd’hui sa décision de suspendre l’administration du traitement aux patients recrutés dans l’étude globale de phase III (PVO-1A-301) destinée à évaluer l’effica…
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fi…
The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial (OPTIC) of TEPEZZA™ (teprotumumab-trbw) for Thyroid Eye Disease
DUBLIN–(BUSINESS WIRE)–The New England Journal of Medicine published Phase 3 trial data for Horizon Therapeutics’ TEPEZZA™ (teprotumumab-trbw) for Thyroid Eye Disease.
Tangible Science Announces Successful 2019 and Timing for Tangible Boost Launch
REDWOOD CITY, Calif.–(BUSINESS WIRE)– #GSLS–Tangible Science recaps 2019 highlights and sets timing for launch of Tangible Boost, a conditioner that repairs wear on coated contact lenses.
Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
FARMINGTON HILLS, Michigan–(BUSINESS WIRE)–Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, today announced that it …
Il Medical Retina Center (istituto al vertice) in Italia adotta EyeArt AI Eye Screening System di Eyenuk
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc. azienda globale specializzata in tecnologia medica manovrata da intelligenza artificiale (IA) e servizi e protagonista nelle applicazioni del mondo reale per AI Eye Screening™, oggi ha annunciato che il Medical…